Cochlear Limited
Research Cochlear Limited (OC5) on Bullrun: market cap EUR 4.68B, P/E 22.4, dividend yield 3.6%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerOC5
- ExchangeF
- CountryAustralia
- SectorHealthcare
- IndustryMedical Devices
- CurrencyEUR
- Market capEUR 4.68B
- P/E22.4
- Dividend yield3.6%
- Financial periodFY2025
- RevenueEUR 2.34B
- Revenue growth4.8%
- Net incomeEUR 388.90M
- Free cash flowEUR 135.00M
- Gross margin73.7%
Valuation Snapshot
latest market cap is EUR 4.68B; P/E is 22.4; dividend yield is 3.6%.
About Cochlear Limited
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. The company offers cochlear implant systems, sound processor upgrades, bone conduction systems, and other products. It also provides cochlear nucleus systems, including Nucleus sound processors, smart bimodal hearing solution, and Nucleus implants; cochlear Baha systems comprising Baha 6 max sound processor and Baha implant; and accessories, such as wireless devices and Nucleus water-safe accessories.
Frequently asked questions
What is Cochlear Limited's market cap?
Cochlear Limited's market capitalization is EUR 4.68B.
What is Cochlear Limited's P/E ratio?
Cochlear Limited's price-to-earnings (P/E) ratio is 22.4.
Does Cochlear Limited pay a dividend?
Cochlear Limited has a dividend yield of 3.6%.
What does Cochlear Limited do?
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. The company offers cochlear implant systems, sound processor upgrades, bone conduction systems, and other products.